Soluble Thrombomodulin
BRD ID: 2,041
Source: TCP Project Tier: SOP Number of times downloaded: 662
Description
This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical
Center (BMC) to quantify levels of soluble thrombomodulin (sTM) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).
Documents for Download
BARC PRO 025 Souble Thrombomodulin Removed Hidden Fields Size Reduced.pdf [Size: 776 KB]Biospecimens
- Fluid - Plasma
Diagnoses
- Normal
- Neoplastic - Carcinoma
Topics
- Biospecimen Processing
- Platform-specific Methodology
Associated SOP Compendiums
- Biospecimen Processing
- Platform-specific Methodology